Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Loken

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Nature Medicine|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trialJohn F DiPersio, Guenther Koehne, Nirali N Shah, et al.
The Journal of Clinical Investigation|August 15, 2024
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell targetQuy Le, Brandon Hadland, Jenny L Smith, et al.
The Journal of Clinical Investigation|September 22, 2022
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell targetQuy Le, Brandon Hadland, Jenny L Smith, et al.
Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.
Haematologica|October 21, 2016
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M Westers, Eline M P Cremers, Uta Oelschlaegel, et al.
Blood Cancer Discovery|May 21, 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN studyCurtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, et al.
Cytometry. Part B, Clinical Cytometry|December 11, 2021
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNetVincent H J van der Velden, Frank Preijers, Ulrika Johansson, et al.
Cytometry. Part B, Clinical Cytometry|December 20, 2022
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working GroupAnna Porwit, Marie C Béné, Carolien Duetz, et al.
Cytometry. Part B, Clinical Cytometry|December 13, 2021
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working GroupArjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, et al.
Haematologica|June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesArjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Nature Medicine|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trialJohn F DiPersio, Guenther Koehne, Nirali N Shah, et al.
The Journal of Clinical Investigation|August 15, 2024
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell targetQuy Le, Brandon Hadland, Jenny L Smith, et al.
The Journal of Clinical Investigation|September 22, 2022
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell targetQuy Le, Brandon Hadland, Jenny L Smith, et al.
Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.
Haematologica|October 21, 2016
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M Westers, Eline M P Cremers, Uta Oelschlaegel, et al.
Blood Cancer Discovery|May 21, 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN studyCurtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, et al.
Cytometry. Part B, Clinical Cytometry|December 11, 2021
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNetVincent H J van der Velden, Frank Preijers, Ulrika Johansson, et al.
Cytometry. Part B, Clinical Cytometry|December 20, 2022
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working GroupAnna Porwit, Marie C Béné, Carolien Duetz, et al.
Cytometry. Part B, Clinical Cytometry|December 13, 2021
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working GroupArjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, et al.
Haematologica|June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesArjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Pageof 10